In a recent review (Garcia et al., 2011), the lifetime prevalence of AN was estimated to be 1.9% in female adults to 2.6% in female adolescents in industrialized countries
Professor Receives Grant to Study Effectiveness of GLP-1 Weight-Loss Drugs Andrew Stokes, associate professor of global health, has received a grant from the Robert Wood Johnson Foundation to analyze the real-world effectiveness of this new class of therapies and inequities in access to these medications
[1] Whilst night sweats are not listed as an adverse effect in the official Summary of Product Characteristics (SmPC) or patient information leaflet, some individuals taking Mounjaro have reported experiencing episodes of nocturnal perspiration
(2014) reveal a link between intestinal dysfunction and cognitive dysfunction, they are often limited by their small sample sizes, heterogeneous patient populations, and insufficient control for confounding factors such as comorbidities, medication, nutritional status, and psychological stress
Kalanithi PSA, Zheng W, Kataoka Y, et al